Contact Lenses Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Contact Lenses Pipeline Market Report Overview

Contact lenses are a corrective, cosmetic, or therapeutic lens placed on the cornea of the eye. The Contact Lenses pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Japan

·       India

·       Israel

Key Categories ·       Soft Contact Lenses

·       Rigid Gas Permeable Contact Lenses

Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       HSA

·       Ninsho

Leading Companies ·       Aeon Astron Corporation

·       Ai Kangte Medical Technology Co Ltd

·       Alcon Inc

·       Alcon Laboratories Inc

·       Apeliotus Ophthalmics (Inactive)

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Contact Lenses Pipeline Market Segmentation by Categories

The key categories in the Contact Lenses pipeline market are Soft Contact Lenses and Rigid Gas Permeable Contact Lenses. As of September 2024, Soft Contact Lenses had the highest number of pipeline products.

Contact Lenses Pipeline Market Analysis by Categories, As of September 2024 (%)

Contact Lenses Pipeline Market Analysis by Categories, As of September 2024 (%)

Buy the Full Report for More Category Insights into the Contact Lenses Pipeline Market

Download a Free Report Sample

Contact Lenses Pipeline Market Segmentation by Territories

A few of the key territories associated with the Contact Lenses pipeline market are Europe, the United States, India, Japan, and Israel among others. As of September 2024, the US had the highest number of Contact Lenses pipeline products.

Contact Lenses Pipeline Market Analysis by Territories, As of September 2024 (%)

Contact Lenses Pipeline Market Analysis by Territories, As of September 2024 (%)

Buy the Full Report for More Territory Insights into the Contact Lenses Pipeline Market

Download a Free Report Sample

Contact Lenses Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the Contact Lenses pipeline products market are CE, NMPA, Ninsho, HSA, and 510(k). As of September 2024, 510(k) was the most followed pathway for pipeline products in the Contact Lenses market.

Contact Lenses Pipeline Market Analysis by Regulatory Paths, As of September 2024 (%)

Contact Lenses Pipeline Market Analysis by Regulatory Paths, As of September 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Contact Lenses Pipeline Market

Download a Free Report Sample

Contact Lenses Pipeline Market – Competitive Landscape

A few of the key companies associated with the Contact Lenses pipeline market are Aeon Astron Corporation, Ai Kangte Medical Technology Co Ltd, Alcon Inc, Alcon Laboratories Inc, and Apeliotus Ophthalmics (Inactive) among others.

Alcon Inc (Alcon): Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment.

Apeliotus Ophthalmics (Inactive): Apeliotus Ophthalmics (Apeliotus) is a privately held company engaged in the development of contact lens drug delivery systems. The company is engaged in manufacturing contact lenses and its products includes Bandage Lens 67, Comfort Lens 67, and Contact Lens –Glaucoma 67. The company is headquartered in Atlanta, Georgia, the US.

Contact Lenses Pipeline Market Analysis by Companies, As of September 2024 (%)

Contact Lenses Pipeline Market Analysis by Companies, As of September 2024 (%)Buy the Full Report for More Company Insights into the Contact Lenses Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Contact Lenses Pipeline Market Territories Outlook (As of September 2024)

  • Europe
  • The United States
  • India
  • Japan
  • Israel

Contact Lenses Pipeline Market Regulatory Paths Outlook (As of September 2024)

  • 510(k)
  • NMPA
  • CE
  • HSA
  • Ninsho

Contact Lenses Pipeline Market Categories Outlook (As of September 2024)

  • Soft Contact Lenses
  • Rigid Gas Permeable Contact Lenses

Scope

This report provides:

  • Extensive coverage of the Contact Lenses devices under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Contact Lenses and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Contact Lenses under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aeon Astron Corporation
Ai Kangte Medical Technology Co Ltd
Alcon Inc
Alcon Laboratories Inc
Apeliotus Ophthalmics (Inactive)
Axcelon Biopolymers Corp
Azalea Vision
Bar-Ilan University
Bausch & Lomb Inc
Bionode LLC
Body Organ Biomedical Corp
BVS Sight Inc
Chinese Academy of Sciences
Clerio Vision Inc
Diopter Technologies Inc (Inactive)
Euclid Systems Corp
e-Vision Medical Devices, Inc.
Eyenovations
EyeYon Medical
Fitlens Ltd
iCheck LLC
Imperial College London
Industrial Science & Technology Network Inc
Innovega Inc
Johnson & Johnson Vision Care Inc
Khalifa University
Kubota Vision Inc
Lentechs LLC
Lipocoat BV
Lynthera Corp
Massachusetts Eye and Ear Infirmary
McGowan Institute for Regenerative Medicine
Mojo Vision Inc
National University of Singapore
Novartis AG
Ocular Dynamics, LLC
Ocutec Ltd
PHI Biomed Co Ltd
Purdue University
Queen's University
RetMap Inc
Shamir Optical Industry Ltd
Smartlens Inc
Stanford University
SynergEyes Inc
TECLens LLC
Terasaki Institute for Biomedical Innovation
The University of New South Wales press Limited
University of California
University of California Irvine
University of California San Diego
University of New Hampshire
University of Valencia
University of Washington
Visioneering Technologies Inc
VISTAKON Pharmaceuticals LLC
XPANCEO Research On Natural Science LLC

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Contact Lenses Overview

3 Products under Development

3.1 Contact Lenses – Pipeline Products by Stage of Development

3.2 Contact Lenses – Pipeline Products by Segment

3.3 Contact Lenses – Pipeline Products by Territory

3.4 Contact Lenses – Pipeline Products by Regulatory Path

3.5 Contact Lenses – Pipeline Products by Estimated Approval Date

3.6 Contact Lenses – Ongoing Clinical Trials

4 Contact Lenses – Pipeline Products under Development by Companies

4.1 Contact Lenses Companies – Pipeline Products by Stage of Development

4.2 Contact Lenses – Pipeline Products by Stage of Development

5 Contact Lenses Companies and Product Overview

5.1 Aeon Astron Corporation Company Overview

5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.2 Ai Kangte Medical Technology Co Ltd Company Overview

5.2.1 Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.3 Alcon Inc Company Overview

5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Alcon Laboratories Inc Company Overview

5.4.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Apeliotus Ophthalmics (Inactive) Company Overview

5.5.1 Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.6 Axcelon Biopolymers Corp Company Overview

5.6.1 Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview

5.7 Azalea Vision Company Overview

5.7.1 Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview

5.8 Bar-Ilan University Company Overview

5.8.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview

5.9 Bausch & Lomb Inc Company Overview

5.9.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Bionode LLC Company Overview

5.10.1 Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview

5.11 Body Organ Biomedical Corp Company Overview

5.11.1 Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview

5.12 BVS Sight Inc Company Overview

5.12.1 BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview

5.13 Chinese Academy of Sciences Company Overview

5.13.1 Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview

5.14 Clerio Vision Inc Company Overview

5.14.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.15 Diopter Technologies Inc (Inactive) Company Overview

5.15.1 Diopter Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.16 Euclid Systems Corp Company Overview

5.16.1 Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

5.17 e-Vision Medical Devices, Inc. Company Overview

5.17.1 e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.18 Eyenovations Company Overview

5.18.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview

5.19 EyeYon Medical Company Overview

5.19.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview

5.20 Fitlens Ltd Company Overview

5.20.1 Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.21 iCheck LLC Company Overview

5.21.1 iCheck LLC Pipeline Products & Ongoing Clinical Trials Overview

5.22 Imperial College London Company Overview

5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

5.23 Industrial Science & Technology Network Inc Company Overview

5.23.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview

5.24 Innovega Inc Company Overview

5.24.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview

5.25 Johnson & Johnson Vision Care Inc Company Overview

5.25.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview

5.26 Khalifa University Company Overview

5.26.1 Khalifa University Pipeline Products & Ongoing Clinical Trials Overview

5.27 Kubota Vision Inc Company Overview

5.27.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.28 Lentechs LLC Company Overview

5.28.1 Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview

5.29 Lipocoat BV Company Overview

5.29.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview

5.30 Lynthera Corp Company Overview

5.30.1 Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview

5.31 Massachusetts Eye and Ear Infirmary Company Overview

5.31.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

5.32 McGowan Institute for Regenerative Medicine Company Overview

5.32.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.33 Mojo Vision Inc Company Overview

5.33.1 Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.34 National University of Singapore Company Overview

5.34.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

5.35 Novartis AG Company Overview

5.35.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview

5.36 Ocular Dynamics, LLC Company Overview

5.36.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.37 Ocutec Ltd Company Overview

5.37.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.38 PHI Biomed Co Ltd Company Overview

5.38.1 PHI Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.39 Purdue University Company Overview

5.39.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.40 Queen’s University Company Overview

5.40.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview

5.41 RetMap Inc Company Overview

5.41.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview

5.42 Shamir Optical Industry Ltd Company Overview

5.42.1 Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Smartlens Inc Company Overview

5.43.1 Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Stanford University Company Overview

5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.45 SynergEyes Inc Company Overview

5.45.1 SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 TECLens LLC Company Overview

5.46.1 TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview

5.47 Terasaki Institute for Biomedical Innovation Company Overview

5.47.1 Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview

5.48 The University of New South Wales press Limited Company Overview

5.48.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview

5.49 University of California Company Overview

5.49.1 University of California Pipeline Products & Ongoing Clinical Trials Overview

5.50 University of California Irvine Company Overview

5.50.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview

5.51 University of California San Diego Company Overview

5.51.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

5.52 University of New Hampshire Company Overview

5.52.1 University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview

5.53 University of Valencia Company Overview

5.53.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview

5.54 University of Washington Company Overview

5.54.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.55 Visioneering Technologies Inc Company Overview

5.55.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.56 VISTAKON Pharmaceuticals LLC Company Overview

5.56.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

5.57 XPANCEO Research On Natural Science LLC Company Overview

5.57.1 XPANCEO Research On Natural Science LLC Pipeline Products & Ongoing Clinical Trials Overview

6 Contact Lenses- Recent Developments

6.1 Sep 12, 2024: ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow

6.2 Sep 10, 2024: Marshall B. Ketchum University Names Greta Vines-Douglas as Director of School of Physician Assistant Studies

6.3 Aug 27, 2024: Bruder Healthcare Introduces Eyeleve MGD, A Trusted Eye Drop Formula Under A New Brand

6.4 Aug 24, 2024: Boston Foundation for Sight Receives 510(k) Clearance For BostonSight Specialty Lens

6.5 Aug 23, 2024: The Walman Optical Company Receives 510(K) Clearance for Flexlens Silicone Hydrogel Daily Wear Soft (Hydrophilic) Contact Lens (efrofilcon A)

6.6 Aug 23, 2024: Boston Foundation for Sight Receives 510(k) Clearance For BostonSight Specialty Lens

6.7 Aug 22, 2024: Eyebright Medical Technology Reports Financial Results for H1 of 2024

6.8 Aug 20, 2024: Alcon Announces Results for Three and Six Month Periods Ending June 30, 2024

6.9 Jul 24, 2024: Unicon Optical Receives 510(K) Clearance For OCuSOFT Amenity (linofilcon A) Daily Disposable Contact Lens With HydraSeal

6.10 Jul 15, 2024: St. Shine Optical Receives FDA 510(k) Clearance for Saview SH 38 UV Toric (Senofilcon A) Visibility Tinted Soft Hydrophilic Contact Lens

6.11 Jul 15, 2024: St. Shine Optical Receives FDA 510(k) Clearance for Saview SH 38 UV Multifocal (Senofilcon A) Visibility Tinted Soft Hydrophilic Contact Lens

6.12 Jul 15, 2024: St. Shine Optical Receives FDA 510(k) Clearance for Saview SH 38 UV (Senofilcon A) Visibility Tinted Soft Hydrophilic Contact Lens

6.13 Jun 10, 2024: Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

6.14 Jun 10, 2024: Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

6.15 May 14, 2024: Menicon Notice of Agenda Items for the 67th Annual General Meeting of Shareholders (Election of Directors and Granting Stock Options)

6.16 Apr 28, 2024: Innova Vision Receives Additional 510(K) Clearance For Inifilcon A Silicone Hydrogel Soft Hydrophilic Contact Lens

6.17 Apr 18, 2024: Ray-Ban Maker EssilorLuxottica’s Revenues rose

5.5% in First Quarter

6.18 Apr 16, 2024: Acuity Polymers Receives Additional FDA 510(k) Clearance for Acuity 100 With Tangible Hydra-PEG (hexafocon A) Rigid Gas Permeable Contact Lens

6.19 Apr 16, 2024: Acuity Polymers Receives Additional FDA 510(k) Clearance for Acuity 200 With Tangible Hydra-PEG (fluoroxyfocon A) Rigid Gas Permeable Contact Lens

6.20 Apr 16, 2024: Acuity Polymers Receives Additional FDA 510(k) Clearance for Acuity 100 (hexafocon A) Rigid Gas Permeable Contact Lens

6.21 Apr 16, 2024: Acuity Polymers Receives Additional FDA 510(k) Clearance for Acuity 200 (Fluoroxyfocon A) Rigid Gas Permeable Contact Lens

6.22 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

6.23 Apr 09, 2024: Swiss Pharma Company Novartis to Lay Off 680 Employees from Switzerland and USA Offices in Next 2-3 Years

6.24 Mar 11, 2024: EssilorLuxottica Societe anonyme Full Year 2023 Earnings: EPS Misses Expectations

6.25 Mar 04, 2024: Visionary Optics Receives 510(K) Clearance For Visionary Optics Scleral Contact Lens – Fluoroxyfocon A

6.26 Mar 04, 2024: Visionary Optics Receives Additional 510(K) Clearance For Scleral Contact Lens – Hexafocon A

6.27 Mar 04, 2024: Visionary Optics Receives Additional 510(K) Clearance For Scleral Contact Lens – Hexafocon B

6.28 Mar 04, 2024: Visionary Optics Receives Additional 510(K) Clearance For Scleral Contact Lens – Roflufocon D

6.29 Mar 04, 2024: Visionary Optics Receives Additional 510(K) Clearance For Scleral Contact Lens – Roflufocon E

6.30 Feb 29, 2024: Fielmann Reports Preliminary Financials for FY2023

6.31 Feb 20, 2024: Xpanceo to Develop the First Laboratory Optic Testing System to Accelerate Smart Contact Lens Production Worldwide

6.32 Feb 13, 2024: Metro Optics Receives Additional 510(K) Clearance For Metro Soft Silicone Hydrogel Daily Wear Soft Contact Lens

6.33 Feb 05, 2024: CooperVision Receives Additional FDA 510(k) Clearance for Clariti 1 Day Multifocal (Somofilcon A) Soft -Hydrophilic Daily Disposable Contact Lens UV Blocker

6.34 Feb 01, 2024: Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia

6.35 Jan 29, 2024: Shanghai Conant Optical Co.: Proposed Re-election and Appointment of Supervisors

6.36 Jan 15, 2024: HOYA Lamphun Receives 510(K) Clearance For HOYA Illumina (sorafilcon A) Daily Disposable Soft Contact Lens

6.37 Jan 09, 2024: EssilorLuxottica showcases its smart and hearing aided eyewear innovation with first appearance at CES 2024 in Las Vegas

6.38 Jan 04, 2024: Yung Sheng Optical Receives 510(k) Clearance for Pure Plus UV Aspheric (Otufilcon A) Silicone Soft (hydrophilic) Contact Lens for Daily Wear

6.39 Jan 02, 2024: Fielmann Appoints Steffen Baetjer as Next CFO

6.40 Dec 07, 2023: Alcon Receives Additional 510(K) Clearance For DAILIES TOTAL 1 – Astigmatism

6.41 Nov 29, 2023: Alcon Receives Additional 510(K) Clearance For DAILIES TOTAL1 Multifocal Toric Soft Contact Lens

6.42 Nov 29, 2023: Innova Vision Receives 510(K) Clearance For Inifilcon A Silicone Hydrogel Soft Hydrophilic Contact Lens

6.43 Nov 29, 2023: Alcon Laboratories Receives 510(K) Clearance For DAILIES TOTAL1 Toric

6.44 Oct 19, 2023: EssilorLuxottica Reports Revenue for Q3 of 2023

6.45 Oct 12, 2023: VTI Announces Positive Interim 1-Year Data From the Protect Clinical Trial at American Academy of Optometry Annual Meeting

6.46 Oct 10, 2023: Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia

6.47 Sep 26, 2023: Art Optical Contact Lens Receives Additional 510(k) Clearance for lntelliWave Contact Lenses

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Contact Lenses – Pipeline Products by Stage of Development

Contact Lenses – Pipeline Products by Segment

Contact Lenses – Pipeline Products by Territory

Contact Lenses – Pipeline Products by Regulatory Path

Contact Lenses – Pipeline Products by Estimated Approval Date

Contact Lenses – Ongoing Clinical Trials

Contact Lenses Companies – Pipeline Products by Stage of Development

Contact Lenses – Pipeline Products by Stage of Development

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview

Biolens – Product Status

Biolens – Product Description

Contact Lens – Product Status

Contact Lens – Product Description

Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Multifocal Contact Lens (Muti-Focal RGP) – Myopia – Product Status

Multifocal Contact Lens (Muti-Focal RGP) – Myopia – Product Description

Multifocal Contact Lens (Muti-Focal RGP) – Ocular Surface Disease – Product Status

Multifocal Contact Lens (Muti-Focal RGP) – Ocular Surface Disease – Product Description

Multifocal Contact Lens (Muti-Focal RGP) – Vision Correction – Product Status

Multifocal Contact Lens (Muti-Focal RGP) – Vision Correction – Product Description

Orthokeratology Lens – Myopia – Product Status

Orthokeratology Lens – Myopia – Product Description

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Status

Air Optix Plus HydraGlyde Toric Reusable Lens – Product Description

Dailies Total 1 Colors SiHy Lens – Product Status

Dailies Total 1 Colors SiHy Lens – Product Description

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Status

Dailies Total 1 Precision 1 Toric SiHy Lens – Product Description

Weekly WG SiHy Lens – Product Status

Weekly WG SiHy Lens – Product Description

Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview

Precision7 For Astigmatism (Serafilcon A) Toric Soft Contact Lens – Product Status

Precision7 For Astigmatism (Serafilcon A) Toric Soft Contact Lens – Product Description

Precision7 Multifocal Toric (Serafilcon A) Soft Contact Lens – Product Status

Precision7 Multifocal Toric (Serafilcon A) Soft Contact Lens – Product Description

Total30 For Astigmatism – Product Status

Total30 For Astigmatism – Product Description

Total30 Multifocal Toric – Product Status

Total30 Multifocal Toric – Product Description

TOTAL30 Soft Contact Lenses – Product Status

TOTAL30 Soft Contact Lenses – Product Description

Alcon Laboratories Inc – Ongoing Clinical Trials Overview

TOTAL30 Soft Contact Lenses – Performance of TOTAL30 (Lehfilcon A) Contact Lenses in Patients Using Digital Devices and 89814415

TOTAL30 Soft Contact Lenses – Post-market Clinical Follow-up Study of Alcon TOTAL30 Spherical Contact Lenses (Lehfilcon A) and TOTAL30 for Astigmatism Contact Lenses (Lehfilcon A)

Total30 For Astigmatism – How Does Total30 for Astigmatism Perform During a Long Day of Wear?

Total30 For Astigmatism – Performance of Total30 for Astigmatism in Digital Device Users

Total30 For Astigmatism – Post-market Clinical Follow-up Study of Alcon TOTAL30 Spherical Contact Lenses (Lehfilcon A) and TOTAL30 for Astigmatism Contact Lenses (Lehfilcon A)

Total30 Multifocal Toric – Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Comfort Lens – Product Status

Comfort Lens – Product Description

Contact Lens – Glaucoma – Product Status

Contact Lens – Glaucoma – Product Description

Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview

PolyHEMA-BNC Based Contact Lens – Product Status

PolyHEMA-BNC Based Contact Lens – Product Description

Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview

Smart Contact Lens – Product Status

Smart Contact Lens – Product Description

Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview

Bionic Contact Lens – Product Status

Bionic Contact Lens – Product Description

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

BLC – 001: SVS – Product Status

BLC – 001: SVS – Product Description

BLC – 002: SVS – Product Status

BLC – 002: SVS – Product Description

BLC – 003: SVS/MF/fA – Product Status

BLC – 003: SVS/MF/fA – Product Description

BLC – 004: Toric – Product Status

BLC – 004: Toric – Product Description

BLC – 005: SVS/MF – Product Status

BLC – 005: SVS/MF – Product Description

BLC – 006: SVS – Product Status

BLC – 006: SVS – Product Description

BLC – 007: MF – Product Status

BLC – 007: MF – Product Description

BLC – 008: Astigmatism – Product Status

BLC – 008: Astigmatism – Product Description

BLC – 009: Astigmatism – Product Status

BLC – 009: Astigmatism – Product Description

Contact Lens – Myopia – Product Status

Contact Lens – Myopia – Product Description

Myopia Control Contact Lens – Product Status

Myopia Control Contact Lens – Product Description

SiHy Daily Multi-Focal Lens – Product Status

SiHy Daily Multi-Focal Lens – Product Description

SiHy Daily Toric Lens – Product Status

SiHy Daily Toric Lens – Product Description

Ultra Plus Powers Lens – Product Status

Ultra Plus Powers Lens – Product Description

XUV – 003: Aphakia – Product Status

XUV – 003: Aphakia – Product Description

XUV – 004: SVS – Product Status

XUV – 004: SVS – Product Description

XUV – 007: MF – Product Status

XUV – 007: MF – Product Description

XUV – 009: SVS – Product Status

XUV – 009: SVS – Product Description

XUV – 010: Astigmatism – Product Status

XUV – 010: Astigmatism – Product Description

XUV – 011: MF – Product Status

XUV – 011: MF – Product Description

XUV – 012: SVS – Product Status

XUV – 012: SVS – Product Description

XUV – 013: Astigmatism – Product Status

XUV – 013: Astigmatism – Product Description

XUV – 014: Presbyopia – Product Status

XUV – 014: Presbyopia – Product Description

XUV – 015: MF – Product Status

XUV – 015: MF – Product Description

Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview

Bionode IOP Lowering System – Product Status

Bionode IOP Lowering System – Product Description

Body Organ Biomedical Corp Pipeline Products & Ongoing Clinical Trials Overview

Collagen Lens – Product Status

Collagen Lens – Product Description

BVS Sight Inc Pipeline Products & Ongoing Clinical Trials Overview

Smart Contact Lens – Product Status

Smart Contact Lens – Product Description

Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview

Smart Contact Lens – Eye Health Monitoring – Product Status

Smart Contact Lens – Eye Health Monitoring – Product Description

Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

Bifocal Contact Lens – Product Status

Bifocal Contact Lens – Product Description

Diopter Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Contact Lens – Product Status

Drug Eluting Contact Lens – Product Description

Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Contact Lenses – Product Status

Drug-Eluting Contact Lenses – Product Description

e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Electronic Contact Lens – Product Status

Electronic Contact Lens – Product Description

Eyenovations Pipeline Products & Ongoing Clinical Trials Overview

Drug Dispensing Contact Lens – Product Status

Drug Dispensing Contact Lens – Product Description

EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview

Hyper-CL – Drug Delivery – Product Status

Hyper-CL – Drug Delivery – Product Description

Fitlens Ltd Pipeline Products & Ongoing Clinical Trials Overview

Myolens – Product Status

Myolens – Product Description

Fitlens Ltd – Ongoing Clinical Trials Overview

Myolens – An Open Label, 3 Arms, Multicenter, Randomized. To Evaluate the Effectiveness Fitlens Soft Central Near and Central Far Contact Lens, Compared With MiSight for the Control of Progressive Juvenile Onset Myopia in Children Ages 8-12

iCheck LLC Pipeline Products & Ongoing Clinical Trials Overview

iCheck Active Contact Lens – Product Status

iCheck Active Contact Lens – Product Description

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

Contact Lens – Product Status

Contact Lens – Product Description

Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview

Silicone Hydrogel Contact Lens – Product Status

Silicone Hydrogel Contact Lens – Product Description

Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview

eMacula VR Contact Lenses – Product Status

eMacula VR Contact Lenses – Product Description

iOptik Contact Lens – Product Status

iOptik Contact Lens – Product Description

Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Status

Next Generation 1-DAY ACUVUE DEFINE Contact Lens – Product Description

Xlens – Product Status

Xlens – Product Description

Khalifa University Pipeline Products & Ongoing Clinical Trials Overview

Gold Nanocomposite Contact Lens – Product Status

Gold Nanocomposite Contact Lens – Product Description

Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

Smart Contact Lens – Myopia – Product Status

Smart Contact Lens – Myopia – Product Description

Lentechs LLC Pipeline Products & Ongoing Clinical Trials Overview

Apioc – Astigmatism – Product Status

Apioc – Astigmatism – Product Description

Apioc – Presbyopia – Product Status

Apioc – Presbyopia – Product Description

Apioc – Presbyopia With Astigmatism – Product Status

Apioc – Presbyopia With Astigmatism – Product Description

Apioc Sphere – Astigmatism – Product Status

Apioc Sphere – Astigmatism – Product Description

Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview

Lipocoat-Enabled Contact Lens – Product Status

Lipocoat-Enabled Contact Lens – Product Description

Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview

Contact Lens Device – Dry Eye Disease – Product Status

Contact Lens Device – Dry Eye Disease – Product Description

Drug-Delivering Contact Lens (DDCL) – Product Status

Drug-Delivering Contact Lens (DDCL) – Product Description

Ketotifen Drug Delivery Contact Lens – Product Status

Ketotifen Drug Delivery Contact Lens – Product Description

Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

Therapeutic Contact Lens – Product Status

Therapeutic Contact Lens – Product Description

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview

Drug-Eluting Contact Lens – Product Status

Drug-Eluting Contact Lens – Product Description

Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

Mojo Lens – Product Status

Mojo Lens – Product Description

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

Multi – Focal Contact Lens – Product Status

Multi – Focal Contact Lens – Product Description

Novartis AG Pipeline Products & Ongoing Clinical Trials Overview

CLM041 – Product Status

CLM041 – Product Description

Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview

Bio-inspired Contact Lens – Dry Eye Disease – Product Status

Bio-inspired Contact Lens – Dry Eye Disease – Product Description

Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview

Third PEG Hydrogel Contact Lens – Product Status

Third PEG Hydrogel Contact Lens – Product Description

PHI Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Smart LED Contact Lens – Product Status

Smart LED Contact Lens – Product Description

Purdue University Pipeline Products & Ongoing Clinical Trials Overview

Soft Contact Lens – Product Status

Soft Contact Lens – Product Description

Soft Contact Lens – Ocular Disease Monitoring – Product Status

Soft Contact Lens – Ocular Disease Monitoring – Product Description

Queen’s University Pipeline Products & Ongoing Clinical Trials Overview

Non-Invasive IOP Monitoring Soft Contact Lens – Product Status

Non-Invasive IOP Monitoring Soft Contact Lens – Product Description

RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview

CLEAr Lens – Product Status

CLEAr Lens – Product Description

Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview

MyLens – Product Status

MyLens – Product Description

Smartlens Inc Pipeline Products & Ongoing Clinical Trials Overview

miLens – Product Status

miLens – Product Description

Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Polymer Network Hydrogel Contact Lens – Product Status

Polymer Network Hydrogel Contact Lens – Product Description

SynergEyes Inc Pipeline Products & Ongoing Clinical Trials Overview

ScanFitPRO – Product Status

ScanFitPRO – Product Description

TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview

CXLens Device – Product Status

CXLens Device – Product Description

TECLens LLC – Ongoing Clinical Trials Overview

CXLens Device – A Pilot Clinical Study for the Treatment of Keratoconus using the TECLens CXLens on-eye Cross-linking System for Corneal Remodeling

Terasaki Institute for Biomedical Innovation Pipeline Products & Ongoing Clinical Trials Overview

Hydrogel Contact Lens – Biomarker Sensing – Product Status

Hydrogel Contact Lens – Biomarker Sensing – Product Description

The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview

Stem Cell Contact Lens – Product Status

Stem Cell Contact Lens – Product Description

University of California Pipeline Products & Ongoing Clinical Trials Overview

Bandage Contact Lens – Product Status

Bandage Contact Lens – Product Description

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview

Drug Eluting Contact Lens – Product Status

Drug Eluting Contact Lens – Product Description

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Telescopic Contact Lens – Product Status

Telescopic Contact Lens – Product Description

University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview

Hydrogel Contact Lens – Product Status

Hydrogel Contact Lens – Product Description

University of Valencia Pipeline Products & Ongoing Clinical Trials Overview

Multifocal Contact Lens – Myopia – Product Status

Multifocal Contact Lens – Myopia – Product Description

Multifocal Contact Lens – Presbyopia – Product Status

Multifocal Contact Lens – Presbyopia – Product Description

University of Washington Pipeline Products & Ongoing Clinical Trials Overview

Bionic Contact Lens – Product Status

Bionic Contact Lens – Product Description

Solar Powered Augmented Lenses – Product Status

Solar Powered Augmented Lenses – Product Description

Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Bespoke Corneal GP Lenses – Product Status

Bespoke Corneal GP Lenses – Product Description

Contact Lens – Product Status

Contact Lens – Product Description

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Status

NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses – Product Description

NaturalVue Toric 1 Day Contact Lenses – Product Status

NaturalVue Toric 1 Day Contact Lenses – Product Description

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Status

NaturalVue Toric Multifocal 1 Day Contact Lenses – Product Description

Next Gen NaturalVue MF Contact Lens – Product Status

Next Gen NaturalVue MF Contact Lens – Product Description

VTI MPC Lens – Product Status

VTI MPC Lens – Product Description

VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview

K-Lens – Product Status

K-Lens – Product Description

XPANCEO Research On Natural Science LLC Pipeline Products & Ongoing Clinical Trials Overview

XR Smart Contact Lenses – Product Status

XR Smart Contact Lenses – Product Description

Glossary

Figures

Contact Lenses – Pipeline Products by Stage of Development

Contact Lenses – Pipeline Products by Segment

Contact Lenses – Pipeline Products by Territory

Contact Lenses – Pipeline Products by Regulatory Path

Contact Lenses – Pipeline Products by Estimated Approval Date

Contact Lenses – Ongoing Clinical Trials

Frequently asked questions

Contact Lenses Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Contact Lenses Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Contact Lenses Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Contact Lenses Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.